本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kura Oncology, Inc

10.41
-0.1950-1.84%
成交量:50.29万
成交额:526.15万
市值:9.24亿
市盈率:-3.09
高:10.68
开:10.60
低:10.36
收:10.60
52周最高:13.90
52周最低:7.36
股本:8,877.44万
流通股本:7,060.22万
量比:0.69
换手率:0.71%
股息:- -
股息率:- -
每股收益(TTM):-3.3668
每股收益(LYR):-3.1784
净资产收益率:-167.71%
总资产收益率:-31.30%
市净率:19.07
市盈率(LYR):-3.27

数据加载中...

2026/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/09

重要事件披露

Form 8-K - Current report
2026/09/08

重要事件披露

Form 8-K - Current report
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/30

重要事件披露

Form 8-K - Current report
2026/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans